$0.9052
-0.0301-3.22%
Last update: Nov 12, 10:35 AM
Allarity Therapeutics Inc (ALLR) Stock Price, Quote, News & History
ALLRNASDAQ
Allarity Therapeutics receives a Wells Notice from the SEC regarding disclosures about their FDA meetings for the New Drug Application of dovitinib.
You can purchase shares of Allarity Therapeutics (NASDAQ:ALLR) through any online brokerage.
Other companies in Allarity Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Allarity Therapeutics has a consensus price target of $11.00.
The stock price for Allarity Therapeutics (NASDAQ: ALLR) is $0.9052 last updated November 12, 2026 at 10:35 AM EST.
There are no upcoming dividends for Allarity Therapeutics.
Allarity Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Allarity Therapeutics.
Allarity Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib,...
